CD4 and neoplasm: Surprisingly, the regulatory core displayed a positive correlation with the patient’s outcome, which is aligned with Zhang et al.41 observations, where the Treg depletion promotes the tumor progression through CD4+/myeloid cell immune-suppressive function and the myCAF depletion.